Cat. No. 334 002
|
200 µl antiserum, lyophilized. For reconstitution add 200 µl H2O, then aliquot and store at -20°C until use. Antibodies should be stored at +4°C when still lyophilized. Do not freeze!
|
Applications
|
WB: 1 : 1000 (AP staining) (see remarks) gallery IP: not tested yet ICC: not tested yet IHC: not tested yet IHC-P: not tested yet
Western blot (WB); separation of proteins by PAGE and subsequent transfer to a membrane. Detection of target molecules is carried out with antibodies. Some antibodies require special sample preparation steps. For details, please refer to the “Remarks” section.
Immunoprecipitation (IP); Immunoisolation or pulldown of a target molecule using an antibody. For details and product specific hints, please refer to the ”Remarks” section.
Immunocytochemistry (ICC) on 4% PFA fixed cells. Immunoreactivity is usually revealed by fluorescence. Some antibodies require special fixation methods. For details, please refer to the “Remarks” section.
Immunohistochemistry (IHC) on 4% PFA perfusion fixed tissue with 24h PFA post fixation. Immunoreactivity is usually revealed by fluorescence or a chromogenic substrate. Some antibodies require special fixation methods or antigen retrieval steps. For details, please refer to the ”Remarks” section.
Immunohistochemistry (IHC-P) of formalin fixed, paraffin embedded (FFPE) tissue (some antibodies require special antigen retrieval steps, please refer to the ”Remarks” section). Immunoreactivity is usually revealed by fluorescence or a chromogenic substrate.
|
Immunogen
|
Recombinant protein corresponding to AA 1901 to 2169 from rat Ca2+ channel L-type α-1C (Cav1.2) (UniProt Id: P22002)
|
Reactivity
|
Reacts with: rat (P22002), mouse (Q01815). Other species not tested yet.
|
Remarks
|
WB: Due to its large size, Ca-channels require special gel-electrophoresis and Western blot protocols for visualization by immunoblotting. Excellent results can be obtained with NuPage TRIS-acetate gels from Invitrogen.
Non-boiled samples are recommended.
|
Data sheet
|
334_002.pdf
|